← The Wire
RIGLNasdaq
RIGEL PHARMACEUTICALS INC
Pharmaceutical Preparations · DE · CIK 1034842
Develops and provides novel therapies for hematologic disorders and cancer by targeting critical disease signaling pathways
red 8-K · 90d
$608M
Market cap
$39.04
Last close
+0.9%
1D
+9.3%
5D
284K
Volume
Price · last 39 sessions+32.2%
May 4L $26.04 · H $39.04Jun 29
355
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
10-K10-KMar 3, 202610-K10-KMar 4, 202510-K10-KMar 5, 202410-K10-KMar 7, 202310-K10-KMar 1, 202210-K10-KMar 2, 202110-K10-KFeb 27, 202010-K10-KFeb 28, 201910-K10-KMar 6, 201810-K10-KMar 7, 201710-K10-KMar 8, 201610-K10-KMar 3, 201510-K10-KMar 4, 201410-K10-KMar 5, 201310-K10-KMar 6, 201210-K10-KMar 1, 201110-K10-KMar 2, 201010-K10-KFeb 27, 200910-K10-KMar 7, 2008
Insider Activity
In the 90 days to Feb 20, 2026: 1 sold $145K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Moos Walter HDirector | Sell | 4,000 | $36.36 | $145K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance